Botulinum Toxin

Advertisement

cGxPJobs Banner

AEON Biopharma Posts Q3 Gains with Strong ABP-450 Biosimilarity Data

IRVINE, CA — November 14, 2025 — AEON Biopharma announced its third-quarter 2025 financial results, highlighting strong operational progress,...

By cGxPwire Editor
November 14, 2025

Read More

Advertisement

cGxPJobs

Directory